Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Summit Cancer Centers is a U.S. community oncology provider focused on integrated cancer diagnosis, treatment, and supportive care across eastern Washington and north Idaho. The organization offers medical oncology, chemotherapy, immunotherapy, radiation oncology, diagnostic imaging, surgical oncology coordination, onsite oral chemotherapy, laboratory services, and rapid second-opinion support. Summit also operates an active clinical research program that gives patients access to industry-sponsored oncology trials, including studies in advanced solid tumors, urothelial carcinoma, colorectal cancer, and lung cancer. Founded and led clinically by Arvind Chaudhry, MD, PhD, the practice has positioned itself as a regional cancer care network serving patients from the Inland Northwest and surrounding areas. Summit has been affiliated with American Oncology Network since May 2021 while continuing to operate under the Summit Cancer Centers brand.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Summit Cancer Centers.